Anticoagulation for Left Ventricular Thrombosis Post-Myocardial Infarction – Current Recommendations and Future Perspectives

1 Cruz Rodriguez JB, Okajima K, Greenberg BH. Management of left ventricular thrombus: a narrative review. Ann Transl Med. 2021;9(6):520. Cruz RodriguezJB OkajimaK GreenbergBH Management of left ventricular thrombus: a narrative review Ann Transl Med 2021 9 6 520 10.21037/atm-20-7839 Search in Google Scholar

2 Camilli M, Lombardi M, Del Buono MG, et al. Direct oral anticoagulants vs. vitamin K antagonists for the treatment of left ventricular thrombosis: a systematic review of the literature and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2021;7(3):e21–5. CamilliM LombardiM Del BuonoMG Direct oral anticoagulants vs. vitamin K antagonists for the treatment of left ventricular thrombosis: a systematic review of the literature and meta-analysis Eur Heart J Cardiovasc Pharmacother 2021 7 3 e21 5 10.1093/ehjcvp/pvaa134 Search in Google Scholar

3 Massussi M, Scotti A, Lip GYH, Proietti R. Left ventricular thrombosis: new perspectives on an old problem. Eur Heart J Cardiovasc Pharmacother. 2021;7(2):158–67. MassussiM ScottiA LipGYH ProiettiR Left ventricular thrombosis: new perspectives on an old problem Eur Heart J Cardiovasc Pharmacother 2021 7 2 158 67 10.1093/ehjcvp/pvaa066 Search in Google Scholar

4 Matsumoto M, Takei N, Mineki T, Yahata T, Oiwa K. Anticoagulant therapy with dual antiplatelet for left ventricular thrombus following acute myocardial infarction. J Cardiol Cases. 2020;22(3):114–6. MatsumotoM TakeiN MinekiT YahataT OiwaK Anticoagulant therapy with dual antiplatelet for left ventricular thrombus following acute myocardial infarction J Cardiol Cases 2020 22 3 114 6 10.1016/j.jccase.2020.05.012 Search in Google Scholar

5 Delewi R, Zijlstra F, Piek JJ. Left ventricular thrombus formation after acute myocardial infarction. Heart. 2012;98(23):1743–9. DelewiR ZijlstraF PiekJJ Left ventricular thrombus formation after acute myocardial infarction Heart 2012 98 23 1743 9 10.1136/heartjnl-2012-301962 Search in Google Scholar

6 Keren A, Goldberg S, Gottlieb S, et al. Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol. 1990;15(4):790–800. KerenA GoldbergS GottliebS Natural history of left ventricular thrombi: their appearance and resolution in the posthospitalization period of acute myocardial infarction J Am Coll Cardiol 1990 15 4 790 800 10.1016/0735-1097(90)90275-T Search in Google Scholar

7 Weinsaft JW, Kim J, Medicherla CB, et al. Echocardiographic algorithm for post-myocardial infarction LV thrombus: a gatekeeper for thrombus evaluation by delayed enhancement CMR. JACC Cardiovasc Imaging. 2016;9(5):505–15. WeinsaftJW KimJ MedicherlaCB Echocardiographic algorithm for post-myocardial infarction LV thrombus: a gatekeeper for thrombus evaluation by delayed enhancement CMR JACC Cardiovasc Imaging 2016 9 5 505 15 10.1016/j.jcmg.2015.06.017510433626476503 Search in Google Scholar

8 Srichai MB, Junor C, Rodriguez LL, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J. 2006;152(1):75–84. SrichaiMB JunorC RodriguezLL Clinical, imaging, and pathological characteristics of left ventricular thrombus: a comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation Am Heart J 2006 152 1 75 84 10.1016/j.ahj.2005.08.02116824834 Search in Google Scholar

9 Barbieri A, Mantovani F, Bursi F, Faggiano A, Boriani G, Faggiano P. Optimal use of echocardiography in management of thrombosis after anterior myocardial infarction. Echocardiography. 2020;37(8):1287–95. BarbieriA MantovaniF BursiF FaggianoA BorianiG FaggianoP Optimal use of echocardiography in management of thrombosis after anterior myocardial infarction Echocardiography 2020 37 8 1287 95 10.1111/echo.1480832757422 Search in Google Scholar

10 Anwar AM, Nosir YFM, Ajam A, Chamsi-Pasha H. Central role of real-time three-dimensional echocardiography in the assessment of intracardiac thrombi. Int J Cardiovasc Imaging. 2010;26(5):519–26. AnwarAM NosirYFM AjamA Chamsi-PashaH Central role of real-time three-dimensional echocardiography in the assessment of intracardiac thrombi Int J Cardiovasc Imaging 2010 26 5 519 26 10.1007/s10554-010-9593-420131007 Search in Google Scholar

11 Joseph P. Mathew, Ayoub, Chakib M., Alina Nicoara, and Madhav Swaminathan, Eds. Clinical Manual and Review of Transesophageal Echocardiography, Third edition. McGraw-Hill Education, New York, 2019. MathewJoseph P. AyoubChakib M. NicoaraAlina SwaminathanMadhav Eds. Clinical Manual and Review of Transesophageal Echocardiography Third edition McGraw-Hill Education New York 2019 Search in Google Scholar

12 Bulluck H, Chan MHH, Paradies V, et al. Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis. J Cardiovasc Magn Reson. 2018;20(1):72. BulluckH ChanMHH ParadiesV Incidence and predictors of left ventricular thrombus by cardiovascular magnetic resonance in acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis J Cardiovasc Magn Reson 2018 20 1 72 10.1186/s12968-018-0494-3622299130404623 Search in Google Scholar

13 O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guidelines for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):529–55. O’GaraPT KushnerFG AscheimDD 2013 ACCF/AHA guidelines for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 2013 127 4 529 55 10.1161/CIR.0b013e3182742c8423247303 Search in Google Scholar

14 Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160–236. KernanWN OvbiageleB BlackHR Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association Stroke 2014 45 7 2160 236 10.1161/STR.000000000000002424788967 Search in Google Scholar

15 Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–77. IbanezB JamesS AgewallS 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 2018 39 2 119 77 10.1093/eurheartj/ehx39328886621 Search in Google Scholar

16 Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;64(24):e139–228. AmsterdamEA WengerNK BrindisRG 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 2014 64 24 e139 228 10.1016/j.jacc.2014.09.01725260718 Search in Google Scholar

17 Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–467. KleindorferDO TowfighiA ChaturvediS 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association Stroke 2021 52 7 e364 467 10.1161/STR.000000000000037534024117 Search in Google Scholar

18 Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ, American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):7S–47S. GuyattGH AklEA CrowtherM GuttermanDD SchuünemannHJ American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines Chest 2012 141 2 Suppl 7S 47S 10.1378/chest.1412S3327806022315257 Search in Google Scholar

19 Kontny F, Dale J, Abildgaard U, Hegrenaes L, Lem P, Morstøl T. Adverse effect of warfarin in acute myocardial infarction: increased left ventricular thrombus formation in patients not treated with high-dose heparin. Eur Heart J. 1993;14(8):1040–3. KontnyF DaleJ AbildgaardU HegrenaesL LemP MorstølT Adverse effect of warfarin in acute myocardial infarction: increased left ventricular thrombus formation in patients not treated with high-dose heparin Eur Heart J 1993 14 8 1040 3 10.1093/eurheartj/14.8.10408404934 Search in Google Scholar

20 Ebrahimi M, Fazlinezhad A, Alvandi-Azari M, Abdar Esfahani M. Long-term clinical outcomes of the left ventricular thrombus in patients with ST-elevation anterior myocardial infarction. ARYA Atheroscler. 2015;11(1):1–4. EbrahimiM FazlinezhadA Alvandi-AzariM Abdar EsfahaniM Long-term clinical outcomes of the left ventricular thrombus in patients with ST-elevation anterior myocardial infarction ARYA Atheroscler 2015 11 1 1 4 Search in Google Scholar

21 Mearns ES, White CM, Kohn CG, et al. Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thromb J. 2014;12:14. MearnsES WhiteCM KohnCG Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression Thromb J 2014 12 14 10.1186/1477-9560-12-14409492625024644 Search in Google Scholar

22 Ansell J, Hollowell J, Pengo V, Martinez-Brotons F, Caro J, Drouet L. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM). J Thromb Thrombolysis. 2007;23(2):83–91. AnsellJ HollowellJ PengoV Martinez-BrotonsF CaroJ DrouetL Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM) J Thromb Thrombolysis 2007 23 2 83 91 10.1007/s11239-006-9022-717221328 Search in Google Scholar

23 Franco Moreno AI, Martín Díaz RM, García Navarro MJ. Direct oral anticoagulants: An update. Med Clin (Barc). 2018;151(5):198–206. Franco MorenoAI Martín DíazRM García NavarroMJ Direct oral anticoagulants: An update Med Clin (Barc) 2018 151 5 198 206 10.1016/j.medcle.2018.07.005 Search in Google Scholar

24 Tran PN, Tran M-H. Emerging role of direct oral anticoagulants in the management of heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 2018;24(2):201–9. TranPN TranM-H Emerging role of direct oral anticoagulants in the management of heparin-induced thrombocytopenia Clin Appl Thromb Hemost 2018 24 2 201 9 10.1177/1076029617696582 Search in Google Scholar

25 Cohen H, Efthymiou M, Isenberg DA. Use of direct oral anticoagulants in antiphospholipid syndrome. J Thromb Haemost. 2018;16(6):1028–39. CohenH EfthymiouM IsenbergDA Use of direct oral anticoagulants in antiphospholipid syndrome J Thromb Haemost 2018 16 6 1028 39 10.1111/jth.14017 Search in Google Scholar

26 Skelley JW, White CW, Thomason AR. The use of direct oral anticoagulants in inherited thrombophilia. J Thromb Thrombolysis. 2017;43(1):24–30. SkelleyJW WhiteCW ThomasonAR The use of direct oral anticoagulants in inherited thrombophilia J Thromb Thrombolysis 2017 43 1 24 30 10.1007/s11239-016-1428-2 Search in Google Scholar

27 Cochran JM, Jia X, Hamzeh I, Birnbaum Y. Abstract 16411: Direct oral anticoagulant use for left ventricular thrombus: a single-center experience. Circulation. 2018;138:A16411. CochranJM JiaX HamzehI BirnbaumY Abstract 16411: Direct oral anticoagulant use for left ventricular thrombus: a single-center experience Circulation 2018 138 A16411 Search in Google Scholar

28 Fleddermann AM, Hayes CH, Magalski A, Main ML. Efficacy of direct-acting oral anticoagulants in treatment of left ventricular thrombus. Am J Cardiol. 2019;124(3):367–72. FleddermannAM HayesCH MagalskiA MainML Efficacy of direct-acting oral anticoagulants in treatment of left ventricular thrombus Am J Cardiol 2019 124 3 367 72 10.1016/j.amjcard.2019.05.009 Search in Google Scholar

29 Daher J, Da Costa A, Hilaire C, et al. Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists. Clin Drug Investig. 2020;40(4):343–53. DaherJ Da CostaA HilaireC Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists Clin Drug Investig 2020 40 4 343 53 10.1007/s40261-020-00898-3 Search in Google Scholar

30 Guddeti RR, Anwar M, Walters RW, et al. Treatment of left ventricular thrombus with direct oral anticoagulants: a retrospective observational study. Am J Med. 2020;133(12):1488–91. GuddetiRR AnwarM WaltersRW Treatment of left ventricular thrombus with direct oral anticoagulants: a retrospective observational study Am J Med 2020 133 12 1488 91 10.1016/j.amjmed.2020.05.025 Search in Google Scholar

31 Robinson A, Ruth B, Dent J. Direct oral anticoagulants compared to warfarin for left ventricular thrombi: a single-center experience. J Am Coll Cardiol. 2018;71(11):A981. RobinsonA RuthB DentJ Direct oral anticoagulants compared to warfarin for left ventricular thrombi: a single-center experience J Am Coll Cardiol 2018 71 11 A981 10.1016/S0735-1097(18)31522-5 Search in Google Scholar

32 Smetana KS, Dunne J, Parrott K, et al. Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series. J Thromb Thrombolysis. 2017;44(4):519–24. SmetanaKS DunneJ ParrottK Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case series J Thromb Thrombolysis 2017 44 4 519 24 10.1007/s11239-017-1560-728948507 Search in Google Scholar

33 Ali Z, Isom N, Dalia T, et al. Direct oral anticoagulant use in left ventricular thrombus. Thromb J. 2020;18:29. AliZ IsomN DaliaT Direct oral anticoagulant use in left ventricular thrombus Thromb J 2020 18 29 10.1186/s12959-020-00242-x759694433132763 Search in Google Scholar

34 Robinson AA, Trankle CR, Eubanks G, et al. Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi. JAMA Cardiol. 2020;5(6):685–92. RobinsonAA TrankleCR EubanksG Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi JAMA Cardiol 2020 5 6 685 92 10.1001/jamacardio.2020.0652717763932320043 Search in Google Scholar

35 Alcalai R, Butnaru A, Moravsky G, et al. Apixaban versus warfarin in patients with left ventricular thrombus, a prospective multicenter randomized clinical trial. Eur Heart J Cardiovasc Pharmacother. 2021; Jul 19;pvab057. doi: 10.1093/ehjcvp/pvab057. Online ahead of print. AlcalaiR ButnaruA MoravskyG Apixaban versus warfarin in patients with left ventricular thrombus, a prospective multicenter randomized clinical trial Eur Heart J Cardiovasc Pharmacother 2021 Jul 19 pvab057.10.1093/ehjcvp/pvab057 Online ahead of print. 34279598 Open DOISearch in Google Scholar

36 Abdelnabi M, Saleh Y, Fareed A, et al. Comparative study of oral anticoagulation in left ventricular thrombi (No-LVT Trial). J Am Coll Cardiol. 2021;77(12):1590–2. AbdelnabiM SalehY FareedA Comparative study of oral anticoagulation in left ventricular thrombi (No-LVT Trial) J Am Coll Cardiol 2021 77 12 1590 2 10.1016/j.jacc.2021.01.04933766266 Search in Google Scholar

37 Michael F, Natt N, Shurrab M. Direct oral anticoagulants vs vitamin K antagonists in left ventricular thrombi: a systematic review and meta-analysis. CJC Open. 2021;3(9):1169–81. MichaelF NattN ShurrabM Direct oral anticoagulants vs vitamin K antagonists in left ventricular thrombi: a systematic review and meta-analysis CJC Open 2021 3 9 1169 81 10.1016/j.cjco.2021.04.007853123034712941 Search in Google Scholar

38 Gibson CM, Mehran R, Bode C, et al. Prevention of bleeding in patients with atrial fibrillation undergoing PCI. N Engl J Med. 2016;375(25):2423–34. GibsonCM MehranR BodeC Prevention of bleeding in patients with atrial fibrillation undergoing PCI N Engl J Med 2016 375 25 2423 34 10.1056/NEJMoa161159427959713 Search in Google Scholar

39 Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213–60. ValgimigliM BuenoH ByrneRA 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 2018 39 3 213 60 10.1093/eurheartj/ehx41928886622 Search in Google Scholar

40 Habash F, Vallurupalli S. Challenges in management of left ventricular thrombus. Ther AdvCardiovasc Dis. 2017;11(8):203–13. HabashF VallurupalliS Challenges in management of left ventricular thrombus Ther AdvCardiovasc Dis 2017 11 8 203 13 10.1177/1753944717711139593357928589748 Search in Google Scholar